BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10843664)

  • 1. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.
    Gallimore A; Schwarz K; van den Broek M; Hengartner H; Groettrup M
    Mol Immunol; 1998 Jul; 35(10):581-91. PubMed ID: 9823757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities.
    Stoltze L; Dick TP; Deeg M; Pömmerl B; Rammensee HG; Schild H
    Eur J Immunol; 1998 Dec; 28(12):4029-36. PubMed ID: 9862339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
    Lomas M; Hanon E; Tanaka Y; Bangham CRM; Gould KG
    J Gen Virol; 2002 Mar; 83(Pt 3):641-650. PubMed ID: 11842259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
    Cerundolo V; Benham A; Braud V; Mukherjee S; Gould K; Macino B; Neefjes J; Townsend A
    Eur J Immunol; 1997 Jan; 27(1):336-41. PubMed ID: 9022037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.
    Meng L; Mohan R; Kwok BH; Elofsson M; Sin N; Crews CM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10403-8. PubMed ID: 10468620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
    Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
    J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction.
    Rodriguez F; Zhang J; Whitton JL
    J Virol; 1997 Nov; 71(11):8497-503. PubMed ID: 9343207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
    Yang B; Hahn YS; Hahn CS; Braciale TJ
    J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
    Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
    J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.
    Craiu A; Gaczynska M; Akopian T; Gramm CF; Fenteany G; Goldberg AL; Rock KL
    J Biol Chem; 1997 May; 272(20):13437-45. PubMed ID: 9148969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
    López D; Del Val M
    J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.